Morita E et al. |
Production of 15-hydroxyeicosatetraenoic acid by purified human eosinophils and neutrophils. |
1990 |
Scand. J. Immunol. |
pmid:2125361
|
O'Donnell MC and Fiedel BA |
Histamine secretion from human leucocytes stimulated by basophil-derived platelet-activating factor. |
1981 |
Scand. J. Immunol. |
pmid:6171870
|
Morita E et al. |
Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. |
1989 |
Scand. J. Immunol. |
pmid:2544988
|
Renkonen R et al. |
Lymphocyte binding to and penetration through vascular endothelium is stimulated by platelet-activating factor. |
1989 |
Scand. J. Immunol. |
pmid:2602912
|
Lindström P et al. |
Rapid adhesive responses of endothelial cells and of neutrophils induced by leukotriene B4 are mediated by leucocytic adhesion protein CD18. |
1990 |
Scand. J. Immunol. |
pmid:1972589
|
Hilliquin P et al. |
Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis. Influence of parenteral corticosteroids. |
1995 |
Scand. J. Rheumatol. |
pmid:7777830
|
Dulioust A et al. |
Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases. |
1992 |
Scand. J. Rheumatol. |
pmid:1529281
|
Leistad L et al. |
Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage. |
2011 |
Scand. J. Rheumatol. |
pmid:21417548
|
Schaller MD |
[Sepsis syndrome: progress and therapeutic perspectives]. |
1992 |
Schweiz Med Wochenschr |
pmid:1604283
|
Ding Z et al. |
Inhibitory effects of isoproterenol on PAF-induced endothelial cell permeability and morphological changes. |
1996 |
Sci. China, C, Life Sci. |
pmid:8760474
|
Ruan CG et al. |
Studies on monoclonal antibodies against human platelets--a monoclonal antibody to human platelet glycoprotein I--SZ-2. |
1987 |
Sci. Sin., Ser. B, Chem. Biol. Agric. Med. Earth Sci. |
pmid:3659897
|
Voelkel NF et al. |
Nonimmunological production of leukotrienes induced by platelet-activating factor. |
1982 |
Science |
pmid:7123233
|
Thurston G et al. |
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. |
1999 |
Science |
pmid:10617467
|
Kornecki E and Ehrlich YH |
Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. |
1988 |
Science |
pmid:3381103
|
Abisogun AO et al. |
The involvement of platelet activating factor in ovulation. |
1989 |
Science |
pmid:2911750
|
Darius H et al. |
Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. |
1986 |
Science |
pmid:3082008
|
Kornecki E et al. |
Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. |
1984 |
Science |
pmid:6150550
|
Teruel MN and Meyer T |
Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module. |
2002 |
Science |
pmid:11884760
|
Wang R et al. |
[High performance thin layer chromatographic (HPTLC) determination of PAF in cerebrospinal fluid of patients with subarachnoid hemorrhage(SAH)]. |
1999 |
Se Pu |
pmid:12552702
|
Igarashi Y |
[Physiology of sphingosine 1-phosphate: regulation of cell motility and platelet function]. |
1997 |
Seikagaku |
pmid:9431007
|
Sato A and Ebina K |
[Interaction between Asp-hemolysin-related synthetic peptides and oxidized LDL/lysophospholipids]. |
2013 |
Seikagaku |
pmid:23819394
|
Tokumura A and Tsukatani H |
[Antagonists of platelet activating factor]. |
1985 |
Seikagaku |
pmid:3009656
|
Shindou H |
[Lysophospholipid acyltransferase and platelet-activating factor (PAF) biosynthetic enzyme]. |
2008 |
Seikagaku |
pmid:18341030
|
Nakayama R and Saito K |
[PAF and its physiological significance in normal tissue]. |
1988 |
Seikagaku |
pmid:3286791
|
Satouchi K |
[Platelet activating factor (PAF)--a new chemical mediator of inflammation]. |
1983 |
Seikagaku |
pmid:6350499
|
Shindou H |
[Discovery and characterization of novel lysophospholipid acyltransferases]. |
2010 |
Seikagaku |
pmid:21348263
|
Moschos MM et al. |
In Vitro Effects of Anti-Glaucomatous Eye Drops on Platelet-Activating Factor and its Metabolism. |
2017 |
Semin Ophthalmol |
pmid:26270771
|
Felsen D et al. |
Inflammatory mediators and interstitial cystitis. |
1991 |
Semin Urol |
pmid:1853005
|
Moore TL and Weiss TD |
Mediators of inflammation. |
1985 |
Semin. Arthritis Rheum. |
pmid:3936177
|
Lorant DE et al. |
Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. |
1995 |
Semin. Cell Biol. |
pmid:8562922
|
Murer EH |
The role of platelet calcium. |
1985 |
Semin. Hematol. |
pmid:3901271
|
Lian EC |
Pathogenesis of thrombotic thrombocytopenic purpura. |
1987 |
Semin. Hematol. |
pmid:3299722
|
Barnes JL and Venkatachalam MA |
The role of platelets and polycationic mediators in glomerular vascular injury. |
1985 |
Semin. Nephrol. |
pmid:2957770
|
Fischereder M et al. |
Therapeutic strategies in the prevention of acute renal failure. |
1994 |
Semin. Nephrol. |
pmid:8140341
|
Caplan MS et al. |
The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. |
2005 |
Semin. Pediatr. Surg. |
pmid:16084401
|
Frost BL and Caplan MS |
Necrotizing enterocolitis: pathophysiology, platelet-activating factor, and probiotics. |
2013 |
Semin. Pediatr. Surg. |
pmid:23611612
|
Frost BL et al. |
The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. |
2008 |
Semin. Perinatol. |
pmid:18346533
|
Roudebush WE |
Seminal platelet-activating factor. |
2007 |
Semin. Thromb. Hemost. |
pmid:17253192
|
Carveth HJ et al. |
Regulation of platelet-activating factor (PAF) synthesis and PAF-mediated neutrophil adhesion to endothelial cells activated by thrombin. |
1992 |
Semin. Thromb. Hemost. |
pmid:1315452
|
Whatley RE et al. |
Production of platelet-activating factor by endothelial cells. |
1987 |
Semin. Thromb. Hemost. |
pmid:3321437
|
Silvestro L et al. |
Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis. |
1994 |
Semin. Thromb. Hemost. |
pmid:7527938
|
Braquet P et al. |
Effect of platelet-activating factor on platelets and vascular endothelium. |
1989 |
Semin. Thromb. Hemost. |
pmid:2546255
|
Fu JM |
[Effects of platelet activating factor on blood platelets]. |
1989 |
Sheng Li Ke Xue Jin Zhan |
pmid:2549618
|
Yu SQ |
[Effects of platelet-activating factor (PAF) and its antagonists on the male reproduction]. |
1995 |
Sheng Li Ke Xue Jin Zhan |
pmid:7604226
|
Wang YY and Li CL |
[Platelet-activating factor antagonists and asthma]. |
1992 |
Sheng Li Ke Xue Jin Zhan |
pmid:1329195
|
Yin M and Fang ZY |
[Platelet-activating factor]. |
1989 |
Sheng Li Ke Xue Jin Zhan |
pmid:2692167
|
Liu Y and Kang GF |
[Lipid mediators and liver injury]. |
1995 |
Sheng Li Ke Xue Jin Zhan |
pmid:8745570
|
Wu QX |
[Amplification and desensitization in platelet activation]. |
1992 |
Sheng Li Ke Xue Jin Zhan |
pmid:1299958
|
Li SQ |
[Platelet activating factor and cerebral ischemia]. |
1991 |
Sheng Li Ke Xue Jin Zhan |
pmid:1796263
|
Shen YZ and Li CL |
[The pathophysiological role of the platelet activating factor]. |
1991 |
Sheng Li Ke Xue Jin Zhan |
pmid:1796277
|
Zeng NX |
[Platelet activating factor and gastrointestinal mucosa injuries]. |
1991 |
Sheng Li Ke Xue Jin Zhan |
pmid:1947987
|
Chen DC |
[Phosphoinositide metabolism and platelet activation]. |
1987 |
Sheng Li Ke Xue Jin Zhan |
pmid:2838899
|
Hu GL and Guo HS |
[Progress in platelet-activating factor receptor research]. |
1997 |
Sheng Li Ke Xue Jin Zhan |
pmid:10921090
|
Hu DH and Ma CT |
[Effect of platelet activating factor on TxA2, PGI2 and Ca(2+)-ATPase activity in the intra-pulmonary artery smooth muscle cells]. |
1996 |
Sheng Li Xue Bao |
pmid:9389196
|
Zheng HL et al. |
[Role of platelet-activating factor in progesterone synthesis and vascular endothelial growth factor expression in rat luteal cells]. |
2008 |
Sheng Li Xue Bao |
pmid:18425318
|
Tu Q and Zhang QX |
[Stimulation of megakaryocyte maturation and thrombopoiesis in vitro by thrombocytopoiesis-stimulating factor]. |
1990 |
Sheng Li Xue Bao |
pmid:2263959
|
Ma CT |
[Variation of plasma platelet activating factor during development and reversal of hypoxic pulmonary hypertension in conscious sheep]. |
1994 |
Sheng Li Xue Bao |
pmid:7973831
|
Du YM et al. |
Effects of platelet activating factor on action potentials and potassium channels in guinea-pig ventricular myocytes. |
2004 |
Sheng Li Xue Bao |
pmid:15224138
|
Yan GT et al. |
[Effect of calcium overload and platelet activating factor on calcitonin gene related peptide release from lung tissue]. |
1998 |
Sheng Li Xue Bao |
pmid:11324524
|
Jin Y et al. |
[The effect of autocrine factors on development of early embryos of mouse]. |
2001 |
Shi Yan Sheng Wu Xue Bao |
pmid:12549014
|
Mathiak G et al. |
Platelet-activating factor (PAF) in experimental and clinical sepsis. |
1997 |
Shock |
pmid:9185238
|
Kruse-Elliott KT et al. |
Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. |
1998 |
Shock |
pmid:9466472
|
Chen LW et al. |
Differential regulation of Ca2+ influx by fMLP and PAF in human neutrophils: possible involvement of store-operated Ca2+ channel. |
2000 |
Shock |
pmid:10718373
|
Kruse-Elliott KT et al. |
Low molecular weight heparin alters porcine neutrophil responses to platelet-activating factor. |
1998 |
Shock |
pmid:9744648
|
Kruse-Elliott KT et al. |
Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. |
1996 |
Shock |
pmid:8721386
|
Cuschieri J et al. |
Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming. |
2005 |
Shock |
pmid:15665723
|
Wang HG et al. |
The role of endogenous nitric oxide in the sympathetic and hemodynamic response to platelet activating factor-induced hypotension in anesthetized dogs. |
1998 |
Shock |
pmid:9466475
|
Bar-Or D et al. |
Copper stimulates the synthesis and release of interleukin-8 in human endothelial cells: a possible early role in systemic inflammatory responses. |
2003 |
Shock |
pmid:12865660
|
Rios-Santos F et al. |
A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis. |
2003 |
Shock |
pmid:12558146
|
Ruggiero V et al. |
Beneficial effects of a novel platelet-activating factor receptor antagonist, ST 899, on endotoxin-induced shock in mice. |
1994 |
Shock |
pmid:7757521
|
Froon AM et al. |
Treatment with the platelet-activating factor antagonist TCV-309 in patients with severe systemic inflammatory response syndrome: a prospective, multi-center, double-blind, randomized phase II trial. |
1996 |
Shock |
pmid:9156785
|
Buripakdi D and Karlstad MD |
The role of platelet-activating factor in alterations of system A amino acid transport in rat soleus and extensor digitorum longus muscles during endotoxic shock. |
1994 |
Shock |
pmid:7735984
|
Enzan K et al. |
Thromboxane rather than platelet activating factor mediates pulmonary vasoconstriction after antigen challenge in rabbits. |
1996 |
Shock |
pmid:8885083
|
Koch T et al. |
Effects of stroma-free hemoglobin solutions on pulmonary vascular resistance and mediator release in the isolated perfused rabbit lung. |
1994 |
Shock |
pmid:7538430
|
Shouji K et al. |
Platelet-activating factor is a key mediator of pulmonary vasoconstriction and bronchoconstriction after antigen challenge in the perfused sensitized rabbit lung. |
1998 |
Shock |
pmid:9645492
|
Laniyonu AA et al. |
Endotoxin-induced microvascular leakage is prevented by a PAF antagonist and NO synthase inhibitor. |
1997 |
Shock |
pmid:8989836
|
Albert DH et al. |
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats. |
1996 |
Shock |
pmid:8856845
|
Poeze M et al. |
Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group. |
2000 |
Shock |
pmid:11049104
|
Karlstad MD et al. |
Platelet-activating factor (PAF)-induced decreases in whole-body and skeletal muscle protein synthesis. |
2000 |
Shock |
pmid:11049115
|
James JH and Fischer JE |
Are the effects of platelet-activating factor on muscle metabolism of carbohydrates, amino acids and proteins attributable mainly to epinephrine? |
2000 |
Shock |
pmid:11049116
|
Ciesla DJ et al. |
Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. |
2000 |
Shock |
pmid:11028541
|
Childs EW et al. |
In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. |
2002 |
Shock |
pmid:12412620
|
Gomes RN et al. |
Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. |
2006 |
Shock |
pmid:16783197
|
Chen LW et al. |
Thermal injury-induced priming effect of neutrophil is TNF-alpha and P38 dependent. |
2006 |
Shock |
pmid:16783201
|
Klabunde RE and Calvello C |
Inhibition of endotoxin-induced microvascular leakage by a platelet-activating factor antagonist and 5-lipoxygenase inhibitor. |
1995 |
Shock |
pmid:8595525
|
Cureton EL et al. |
Endothelin 1 and prostacyclin attenuate increases in hydraulic permeability caused by platelet-activating factor in rats. |
2010 |
Shock |
pmid:19940814
|
Zallen G et al. |
Postinjury suppression of human neutrophil cytokine production results from the stabilization of inhibitory kappaB. |
1999 |
Shock |
pmid:10030791
|
Granger J and Remick D |
Acute pancreatitis: models, markers, and mediators. |
2005 |
Shock |
pmid:16374372
|
Bulger EM et al. |
The macrophage response to endotoxin requires platelet activating factor. |
2002 |
Shock |
pmid:11900334
|
Mitsuoka H et al. |
Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock. |
2002 |
Shock |
pmid:11900339
|
Mariano F et al. |
Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production. |
2003 |
Shock |
pmid:12688545
|
Park EJ et al. |
Dietary ganglioside inhibits acute inflammatory signals in intestinal mucosa and blood induced by systemic inflammation of Escherichia coli lipopolysaccharide. |
2007 |
Shock |
pmid:17510604
|
Aiboshi J et al. |
Blood transfusion and the two-insult model of post-injury multiple organ failure. |
2001 |
Shock |
pmid:11303730
|
Glaser KB et al. |
Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2. |
1995 |
Skin Pharmacol. |
pmid:8688196
|
Baltás E et al. |
Platelet-activating factor antagonist WEB 2086 inhibits ultraviolet-B radiation-induced dermatitis in the human skin. |
2003 Jul-Aug |
Skin Pharmacol. Appl. Skin Physiol. |
pmid:12784066
|
Wintroub BU and Soter NA |
Biology of the mast cell and its role in cutaneous inflammation. |
1981 |
Springer Semin. Immunopathol. |
pmid:7022722
|
Costa M et al. |
Derivation of endothelial cells from human embryonic stem cells in fully defined medium enables identification of lysophosphatidic acid and platelet activating factor as regulators of eNOS localization. |
2013 |
Stem Cell Res |
pmid:23164599
|
Donnard M et al. |
Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia. |
2002 |
Stem Cells |
pmid:12351810
|
Liu J et al. |
New vernocuminosides from the stem barks of Vernonia cumingiana Benth. |
2009 |
Steroids |
pmid:18840454
|
Leont'ev VK and Kankanian AP |
[The local activation of leukocytes and thrombocytes in periodontal diseases: the role of thrombocyte-activating factor]. |
1996 |
Stomatologiia (Mosk) |
pmid:8658569
|